🇺🇸 FDA
Patent

US 11045466

Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

granted A61KA61K31/255A61K31/496

Quick answer

US patent 11045466 (Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same) held by Platform Brightworks Two, Ltd. expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Platform Brightworks Two, Ltd.
Grant date
Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/255, A61K31/496, A61K47/02, A61K47/10